Pharma Intelligence Podcasts-logo

Pharma Intelligence Podcasts

Business & Economics Podcasts

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Pharma Intelligence is a leader in the field of healthcare industry information.


United States


Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Pharma Intelligence is a leader in the field of healthcare industry information.




China Biotech Podcast on ASCO

Guest speaker Leon Tang Brian Yang in Beijing and Dexter Yan in Shanghai to discuss what stands out in this special episode devoted to ASCO of the latest Chinese-language podcast.


Over The Counter 9 June 2023: Embracing AI/AR Evolution In Beauty, While Navigating Its Hurdles

Over The Counter 9 June 2023: Embracing AI/AR Evolution In Beauty, While Navigating Its Hurdles by Pharma Intelligence


Medtech Connect Episode 6: The Latest And Greatest In Digital Health Regulations

In this episode, MedTech Insight regulatory reporter speaks to Erez Kaminski, CEO and founder of Ketryx, which assists clients in creating FDA-regulated software. He updates us on the latest and greatest in digital health regulations, including PCCPs, decentralized clinical trials and AI/ML software. We talk about some of the challenges and opportunities that often arise from these regulations and Erez shares a personal story about why the safety of medical devices matters so much to him.


항서제약에서 모더나까지: 바이오 기업들이 스위스로 몰리고 있는 이유 (Korean-language podcast)

점점 더 많은 미국과 아시아계 제약바이오 기업들이 스위스에 EU 본부를 설립하고 있는 배경에 대한 Scrip 기사를 요약한 내용입니다.


Scrip’s Five Must-Know Things – 5 June 2023

Quick Listen: Scrip's Five Must-Know Things


Drug Fix: Alzheimer’s Drugs, US FDA’s New Patient Info Leaflet, COVID-19 Vaccine Harmonization

Pink Sheet reporters and editors discuss CMS’s latest coverage announcement for Alzheimer’s drugs and the VA’s approach to the issue (0:29), the FDA’s new one-page patient medication information document (15:55), international convergence on COVID-19 vaccine strain selection (24:48), and Novavax’s place in the vaccine toolbox going forward (28:21). Read More In The Pink Sheet Medicare Registry Plan For Alzheimer’s Drugs Pairs CMS Web Portal With Health System Efforts The US VA And Alzheimer’s: A Misunderstood Decision One-Page Patient Medication Information Document Moves Forward Under Proposed Rule International Regulators Focus On Omicron XBB For Monovalent COVID-19 Vaccine Novavax Readying Multiple COVID-19 Vaccine Candidates To Ensure Fall Availability


Antibody-drug Conjugate Podcast

NSCLC Disease Analysis Report NSCLC Forecast HER2+ Breast Cancer Disease Analysis Report HER2+ Breast Cancer Forecast Other platforms Apple Podcasts - Google Podcasts - TuneIn - Spotify Podcasts -


“Marketing Applications: Best Practices for Publishing”

Regulatory strategists present key publishing strategies to consider when planning your marketing application for successful regulatory outcomes. Don’t miss insights into creating your strongest marketing application strategy, with guidelines from experts at Veristat. You’ll learn more about the important steps to follow for: • Building a publishing-specific team and educating stakeholders about the document submission process • Creating an effective communication strategy • Mitigating delays • Understanding timelines • And much more


“From Benchtop to IND: CMC Pitfalls”

Successfully navigate the complexities of the Chemical, Manufacturing, and Controls (CMC) portions of Investigational New Drug (IND) applications. Listen in as experts provide their insider perspectives on common CMC- and IND- related questions.


Diversity, Equity, and Inclusion Measures Continue to Evolve in the Clinical Space

Listen to expert perspectives on the recent history of DEI in clinical trials and the barriers to patient participation. Listen now to a lively and informative discussion that addresses the questions: • What has changed in patient recruitment strategies from pre- to post-COVID and why? • What factors influenced a new focus on DEI during the time of COVID? • What are the barriers to DEI for patient recruitment in Phase I and Phase II studies? • And more


Scrip’s Five Must-Know Things – 29 May 2023

Quick Listen: Scrip's Five Must-Know Things


Drug Fix: Big Pharma’s US FDA Scorecard, Sarepta’s DMD Gene Therapy Delay, US FDA Adcomm Reforms

Pink Sheet reporters and editors discuss the largest pharma companies’ pending applications (0:41), the FDA delaying its decision on Sarepta’s gene therapy in Duchenne muscular dystrophy (14:32), and a plan to add more temporary members to agency advisory committees (24:55) … as well as a little bit of “The Simpsons.” Read More In The Pink Sheet Everything’s Coming Up Pfizer: The Biggest Of Pharma Firms Leads Industry In Pending Applications For US FDA Approval Big Pharma At US FDA: A Regulatory Scorecard Lilly Unlucky? Lilly Leads Big Pharma In US FDA Complete Response Letters Everybody Stumbles: US FDA Complete Response Letters To Big Pharma Sarepta’s DMD Gene Therapy: Approval Delayed And Indication Narrowed, But Still On Track Expect More Temporary Members Voting In US FDA Advisory Committees


What You Need To Know About HRA/Perrigo’s Historic US OTC Pill Switch With HBW’s Malcolm Spicer

HBW Insight catches up with our own US Executive Editor, Malcolm Spicer, to find out all about Perrigo subsidiary HRA Pharma’s Rx-to-OTC switch of its daily contraceptive, Opill. Currently under consideration by the US Food and Drug Administration after a positive recommendation from its advisory committees, Spicer draws on 30+ years of writing about the US consumer healthcare market, as well as his extensive coverage of the subject, to tell us all we need to know about this historic switch.


Scrip’s Five Must-Know Things – 22 May 2023

Quick Listen: Scrip's Five Must-Know Things


China Biotech Podcast051623

Brian Yang and Dexter Yan discuss the latest China biotech trends and topics including recent mega-million deals between domestic biotechs and MNCs, the inaugural Asia Bio Partnering Forum and drug makers’ creative ways to financing amid lingering “capital winter”, and GLP-1 receptor agonists stepping into the spotlight and its potential to become the next hot pursuit after PD-1 in China.


Digital Health Roundup: HIMSS, Cardio Conversations, ChatGPT And New FDA Guidances

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses how two medtech CEOs are and aren’t using ChatGPT in their businesses while Reed Miller talks about his “Cardio Conversations” podcast interviews with Quentin Blackford, CEO of iRhythm and Rob Krummen, CEO of Vektor Medical. Washington, DC-based reporter Hannah Daniel reviews highlights from the HIMSS conference and the latest updates on FDA guidances. Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode: Cardio Conversations: iRhythm Prepares To Deliver ‘Standard-Of-Care’ Cardiac Monitoring Cardio Conversations: Vektor Addresses ‘Global Health Crisis’ With Arrythmia Mapping HIMSS23 Using The Metaverse To Break Down Language Barriers and Improve Diversity In Clinical Trials Tales From HIMSS23: FDA On FHIR And AI For The Voiceless Decentralized Clinical Trial Guidance Fulfills Promise, Underlies Digitization Of Healthcare Expert: FDA’s Highly Anticipated PCCP Guidance Isn’t Anything Too ‘Surprising’ How Two Medtech CEOs Are (And Aren’t) Using ChatGPT In Their Businesses


Scrip’s Five Must-Know Things – 15 May 2023

Quick Listen: Scrip's Five Must-Know Things:


Cardio Conversations: iRhythm Aspires To ‘Standard-Of-Care’ Monitoring

Quentin Blackford, CEO of iRhythm, talked to Medtech Insight about his company’s plans to bring its Zio long-term cardiac monitoring platform to more patients by building its evidence base and marketing in more countries outside the US. For more information on iRhythm, cardiac monitoring and ECG technologies, check out these articles at Medtech Insight. Cardio Conversations: Vektor Addresses ‘Global Health Crisis’ With Arrythmia Mapping CMS Proposes National Payments For Long-Term Continuous Electrocardiogram Monitoring FDA Clears iRhythm’s Afib-Detecting Wearable Running Software Co-Developed By Verily Exec Chat: As Reimbursement Questions Get Answers, iRhythm Looks To The Future JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet Exec Chat: New iRhythm CEO Foresees Enormous Opportunity In AI For Arrhythmia Detection Dexcom COO Quentin Blackford Takes CEO Job At iRhythm


동아ST에 새로운 변화의 물결이 일다 (Korean-language podcast)

스크립의 박재홍 동아ST R&D 총괄 부문 사장 인터뷰 기사를 요약한 내용입니다


Progressing The Global Self-Care Industry’s Sustainability Agenda With GSCF’s Padmaja Kamath

In this episode, HBW Insight speaks to the Global Self-Care Federation’s director of regulatory and scientific affairs, Padmaja Kamath, about the organisation’s sustainability work. In 2019, GSCF published its Global Charter for Environmental Sustainability, which represented, Kamath notes, the global consumer healthcare industry’s “first commitment to drive sustainable self-care.” Kamath updates us on the progress of the charter, which calls on GSCF members to pledge to make progress on one or more of three key sustainability areas: plastics and packaging, pharmaceuticals in the environment and CO2 footprint. We dive a little deeper into some specific challenges within these areas, such as recyclable blister packs and supply chain emissions, with Kamath pointing also to an upcoming GSCF webinar on the latter.